Изменения толщины хориоидеи при различных глазных заболеваниях на ОКТ

    1. Margolis R, Spide RF. A pilot study of enhanced depth optical coherence tomography of the normal choroid. Am J Ophthalmol. 2009;147: 811–815. doi: 10.1016/j.ajo.2008.12.008

    2. Manjunath V, Taha M, Fujimoto JG, Duker JS. Choroidal thickness in normal eyes measured with Cirrus HD optical coherence tomography. Am J Ophthalmol. 2010;150: 325–329. doi: 10.1016/j. ajo.2010.04.018

    3. Usui S, Ikuno Y, Akiba M, Maruko I, Sekiryu T, Nishida K, Iida T. Circadian changes in subfoveal choroidal thickness and relationships with circulatory factors in healthy individuals. Invest Ophthalmol Vis Science. 2012;53: 2300–2307. doi: 10.1167/ iovs.11-8383

    4. Ikuno Y, Maruko I, Yasuno Y, Miura M, Sekiryu T, Nishida K, Iida T. Reproducibility of retinal and choroidal thickness measurements with advanced depth imaging and high-penetration optical coherence tomography. Invest Ophthalmol Vis Science. 2011;52: 5536–5540. doi: 10.1167/iovs.10-6811

    5. Branchini L, Regatieri CV, Flores-Moreno I, Baumann B, Fujimoto JG, Duiker JS. Reproducibility of choroidal thickness measurements in three spectral domain optical coherence tomography systems. Ophthalmology. 2012;9: 119–123. doi: 10.1016/j.ophtha.2011.07.002

    6. Branchini LA, Adhi M, Regatieri KV, Nandakumar N, Liu JJ, Laver N, Fujimoto JG, Duker JS. Analysis of the morphological features of the choroid and vasculature of healthy eyes using optical coherence tomography in the spectral domain. Ophthalmology. 2013;120: 1901–1908. doi: 10.1016/j.ophtha.2013.01.066

    7. Ozdemir H, Arf S, Karachorlu M. Maküla hastalıklarında optik koherens tomografi. Güneş Tıp Kitabevi. 2014. https:// flipflashpages.uniflip.com/3/34834/341527/pub/document.pdf

    8. Zhang L, Li K, Niemeyer M, Mullins RF, Shonka M. Automated Choroid Segmentation from Clinical SD-OCT Invest Ophthalmol Vis Sci. 2012;53: 7510–7519. doi: 10.1167/iovs.12-10311

    9. Ouyang Y, Heussen FM, Mokwa N, Walsh AS, Durbin MK, Keane A, et al. Spatial distribution of posterior pole choroidal thickness using spectral domain optical coherence tomography Invest Ophthalmol Vis Sci. 2011;52: 7019–7026. doi: 10.1167/iovs.11-8046

    10. Spide RF, Koizumi H, Pozzoni MS. Improved depth imaging in the spectral domain of optical coherence tomography. doi: 10.1016/j. ajo.2008.05.032

    11. Rahman W, Chen FK, Yeo J, Tufail PA, Da Cruz L. Reproducibility of manual subfoveal choroidal thickness measurements in healthy patients using depth-enhanced optical coherence tomography. Invest Ophthalmol Vis Sci. 2011;52: 2267–2271. doi: 10.1167/ iovs.10-6024

    12. Branchini L, Regatieri KV, Flores-Moreno I, Fujimoto JG, Duker JS. Reproducibility of choroidal thickness measurements in three spectral domain optical coherence tomography systems. Ophthalmology. 2012;119: 119–123. doi: 10.1016/j. ophtha.2011.07.002

    13. Chhablani J, Barteselli G, Wang H, El-Emam S, Kozak I, Doede AL, et al., Repeatability and reproducibility of manual choroidal volume measurements using depth-enhanced optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53: 2274–2280. doi: 10.1167/iovs.12-9435

    14. Fujiwara T, Imamura Y, Margolis R, Slakter JS, Spide RF. Enhanced optical coherence tomography of the uvea in high myopia. Am J Ophthalmol. 2009;148: 445–450. doi: 10.1016/j.ajo.2009.04.029

    15. Nishida Y, Fujiwara T, Imamura Y, Lima L.H., Kurosaka D, Spide RF. Choroidal thickness and visual acuity in myopic eyes. Retina. 2012;32: 1229–1236. doi: 10.1097/IAE.0b013e318242b990

    16. Lee HK, Larsen M, Chew IK. Subfoveal choroidal thickness as a function of sex and axial length in 93 Danish university students. Invest Ophthalmol Vis Sci. 2011;52: 8438–8441. doi: 10.1167/ iovs.11-8108

    17. Chen FK, Yeo J, Rahman V, Patel J, Tufail A, Da Cruz L. Topographic variability and interocular symmetry of yellow choroidal thickness using optical coherence tomography with enhanced depth imaging. Invest Ophthalmol Vis Sci. 2012;53: 975–985. doi: 10.1167/iovs.11-8771

    18. Sogawa K, Nagaoka T, Takahashi A, Tanano I, Tani T, Ishibazawa A, et al. Relationship between choroidal thickness and choroidal circulation in healthy young adults. Am J Ophthalmol. 2012;153: 1129–1132. doi: 10.1016/j.ajo.2011.11.005

    19. Kim M, Kim SS, Kwon HJ, Koch HJ, Leeward SK. The relationship between choroidal thickness and ocular perfusion pressure in young, healthy subjects: an optical coherence tomography study with enhanced depth imaging. Invest Ophthalmol Vis Sci. 2012;53: 7710–7717. doi: 10.1167/iovs.12-10464

    20. Alwassia AA, Adhi M, Zhang JY, Regatieri KW, Al-Koutami A, Salem D, et al. Acute exercise-induced changes in systolic blood pressure do not alter choroidal thickness measured with a portable spectral optical coherence tomograph. Retina. 2012;33: 160–165. doi: 10.1097/IAE.0b013e3182618c22

    21. Usui S, Ikuno Y, Miki A, Matsushita K, Yasuno Y, Nishida K. Assessment of choroidal thickness using high-penetration longwavelength optical coherence tomography in high-myopic normal-tension glaucoma. Am J Ophthalmol. 2012;153: 10–16. doi: 10.1016/j.ajo.2011.05.037

    22. Tang KS, Ouyang Y, Ruiz J, Sadda SR. Diurnal variations in choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53: 261–266. doi: 10.1167/iovs.11-8782

    23. Guyer DR, Los Angeles Iannuzzi, Slackter JS, Sorenson JA, Ho A, Orlock D. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol. 1994;112: 1057– 1062. doi: 10.1001/archopht.1994.01090200063023

    24. Manjunath V, Fujimoto JG, Duker JS. Cirrus HD-OCT highdefinition imaging is another available tool for visualizing the choroid and is consistent with the finding that choroidal thickness is increased in central serous chorioretinopathy compared with normal eyes. Retina. 2010;30: 1320–1321. doi: 10.1097/ IAE.0b013e3181e798b1

    25. Imamura Y, Fujiwara T, Margolis R, Spide RF. Improved depth optical coherence tomography of the choroid in central serous chorioretinopathy. Retina. 2009;29: 1469–1473. doi: 10.1097/ IAE.0b013e3181be0a83

    26. Maruko I, Iida T, Sugano Y, Ojima A, Ogasawara M, Spide RF. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology. 2010;117: 1792–1799. doi: 10.1016/j.ophtha.2010.01.023

    27. Jirarattanasopa P, Ooto S, Tsujikawa A, Yamashiro K, Hangai M, Hirata M, et al. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy. Ophthalmology. 2012;119: 1666–1678. doi: 10.1016/j.ophtha.2012.02.021

    28. Pryds A, Larsen M. Choroidal thickness after extrafoveal photodynamic therapy with verteporfin in patients with central serous chorioretinopathy. Acta Ophthalmol. 2011;90: 738–743. doi: 10.1111/j.1755-3768.2011.02157.x

    29. Kim YuT, Kang SV, Bai KH. Choroidal thickness of both eyes in patients with unilateral active central serous chorioretinopathy. Eye (Lond). 2011;25: 1635–1640. doi: 10.1038/eye.2011.258

    30. Iida T, Kishi S, Hagimura N, Shimizu K. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina. 1999;19: 508–512. doi: 10.1097/00006982-199911000-00005

    31. Vance SK, Imamura Y, Freund KB. Effect of sildenafil citrate on choroidal thickness determined by optical coherence tomography with enhanced depth imaging. Retina. 2011;31: 332– 335. doi: 10.1097/IAE.0b013e3181eef0ae

    32. Kim DYu, Silverman RH, Chan RW, Hanifar AA, Rondeau M, Lloyd H, et al. Measurement of choroidal perfusion and thickness after systemic sildenafil. Acta Ophthalmol. 2013;91: 183–188. doi: 10.1111/j.1755-3768.2011.02305.x

    33. Rosenbaum JT. Surveillance of macular degeneration ‒ some inflammatory notes. N Engl J Med. 2012;367: 768–770. doi: 10.1056/NEJMcibr1204973

    34. Friedman E. Hemodynamic model of the pathogenesis of agerelated macular degeneration. Am J Ophthalmol. 1997;124: 677– 682. doi: 10.1016/s0002-9394(14; 70906-7

    35. Harris A, Chang HS, Ciulla TA, Kagemann L. Progress in ocular blood flow measurement and its implications for our understanding of glaucoma and age-related macular degeneration. Prog Retin Eye Res. 1999;18: 669–687. doi: 10.1016/s1350-9462(98; 00037-8

    36. Broekhuise RM. Lipid composition of the aging sclera and cornea. Ophthalmologica. 1975;171: 82–85. doi: 10.1159/000307448

    37. Wood A, Binns A, Margrain T, Drexler W, Povajaj B, Esmaeelpour M, et al. Retinal and choroidal thickness in early age-related macular degeneration. Am J Ophthalmol. 2011;152: 1030–1038. doi: 10.1016/j.ajo.2011.05.021

    38. Chang SE, Kang SW, Lee JH, Kim YT. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology. 2011;118: 840–845. doi: 10.1016/j.ophtha.2010.09.012

    39. Manjunath V, Goren J, Fujimoto JG, Duker JS. Analysis of choroidal thickness in age-related macular degeneration using spectraldomain optical coherence tomography. Am J Ophthalmol. 2011;152: 663–668. doi: 10.1016/j.ajo.2011.03.008

    40. Switzer DV Jr, Mendonβa LS, Saito M, Zweifel SA, Spide RF. Segregation of ophthalmoscopic characteristics by choroidal thickness in patients with early age-related macular degeneration. Retina. 2012;32: 1265–1271. doi: 10.1097/IAE.0b013e31824453ac

    41. Zweifel SA, Imamura Y, Spide TS, Fujiwara T, Spide RF. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen; in age-related macular degeneration. Ophthalmology. 2010;117: 1775–1781. doi: 10.1016/j. ophtha.2010.01.027

    42. Arnold J, Sarks SH, Killingsworth MK, Sarks J. Reticular pseudodrusen. Risk factor for age-related maculopathy. Retina. 1995;15: 183–191. doi: 10.1016/j.ajo.2014.01.023

    43. Querques G, Querques L, Forte R, Massamba N, Coscas F, Soued EH. Choroidal changes associated with reticular pseudodrusen. Invest Ophthalmol Vis Sci. 2012;53: 1258–1263. doi: 10.1167/iovs.11-8907

    44. Jirarattanasopa P, Ooto S, Nakata I, Tsujikawa A, Yamashiro K, Oishi A, et al. Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoid choroidal vasculopathy. Invest Ophthalmol Vis Sci. 2012;53: 3663–3672. doi: 10.1167/iovs.12-9619

    45. Kim SV, Oh J, Kwon SS, Yoo J, Da K. Comparison of choroidal thickness in patients with normal eyes, early age-related maculopathy, neovascular age-related macular degeneration, central serous chorioretinopathy, and polypoidal choroidal vasculopathy. Retina. 2011;31: 1904–1911. doi: 10.1097/ IAE.0b013e31821801c5

    46. 46. Koizumi H, Yamagishi T, Yamazaki T, Kawasaki R, Kinoshita S. Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol. 2011;249: 1123–1128. doi: 10.1007/ s00417-011-1620-1

    47. Uyama M, Matsubara T, Fukushima I, Matsunaga H, Iwashita K, Nagai Y, et al. Idiopathic polypoid choroidal vasculopathy in Japanese patients. Arch Ophthalmol. 1999;117: 1035–1042. doi: 10.1001/archopht.117.8.1035

    48. Los Angeles Iannuzzi, Ciardella A, Spide RF, Rabb M, Freund KB, Orlock DA. Expanding the clinical spectrum of idiopathic polypoid choroidal vasculopathy. Arch Ophthalmol. 1997;115: 478–485. doi: 10.1001/archopht.1997.01100150480005

    49. 49. Los Angeles Yannuzzi, Freund KB, Goldbaum M, ScassellatiSforzolini B, Guyer DR, Spaide RF, et al. Polypoid choroidal vasculopathy masquerading as central serous chorioretinopathy. Ophthalmology. 2000;107: 767–777. doi: 10.1016/s0161- 6420(99; 00173-6

    50. Spide RF, Los Angeles Iannuzzi, Slakter JS, Sorenson J, Orlach DA. Indocyanine green videoangiography of idiopathic polypoid choroidal vasculopathy. Retina. 1995;15: 100–110. doi: 10.1097/00006982-199515020-00003

    51. Sasahara M, Tsujikawa A, Musashi K, Goto N, Ohtani A, Mandai M, et al. Polypoid choroidal vasculopathy with choroidal vascular hyperpermeability. Am J Ophthalmol. 2006;142: 601–607. doi: 10.1016/j.ajo.2006.05.051

    52. Ooto S, Tsujikawa A, Mori S, Tamura H, Yamashiro K, Yoshimura N. Thickness of photoreceptor layers in polypoidal choroidal vasculopathy and central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2010;248: 1077–1086. doi: 10.1007/ s00417-010-1338-5

    53. Yamazaki T, Koizumi H, Yamagishi T, Kinoshita S. Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: results at 12 months. Ophthalmology. 2012;119: 1621–1627. doi: 10.1016/j. ophtha.2012.02.022

    54. Bird AS, Marshall J. Retinal pigment epithelial detachments in the elderly. Trans Ophthalmol Soc UK. 1986;105: 674–682. doi: 10.1136/bjo.69.6.397

    55. Moore DJ, Hussain AA, Marshall J. Age-related changes in hydraulic conductivity of Bruch’s membrane. Invest Ophthalmol Vis Sci. 1995;36: 1290–1297.

    56. Casswell AG, Cohen D, Bird AS. Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol. 1985;69: 397–403. doi: 10.1016/j. survophthal.2007.02.008

    57. Spide RF. Improved depth optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol. 2009;147: 644–652. doi: 10.1016/j.ajo.2008.10.005

    58. Coscas F, Coscas J, Querques J, Massamba N, Querques L, Bandello F, et al. Optical coherence tomography of fibrovascular pigment epithelium with enhanced depth imaging. Invest Ophthalmol Vis Sci. 2012;53: 4147–4151. doi: 10.1167/iovs.12-9878

    59. Rao NA. Pathology of Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2007;27: 81–85. doi: 10.1007/s10792-006-9029-2

    60. Maruko I, Iida T, Sugano Y, Oyamada H, Sekiryu T, Fujiwara T, et al. Subfoveal choroidal thickness after treatment of VogtKoyanagi-Harada disease. Retina. 2011;31: 510–517. doi: 10.1097/ IAE.0b013e3181eef053

    61. Nakai K, Gomi F, Ikuno Y, Yasuno Y, Nushi T, Ohguro N, et al. Observations of choroidal Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2012;250: 1089–1095. doi: 10.1007/ s00417-011-1910-7

    62. Fong AH, Lee KK, Wong D. Choroidal evaluation using extended depth spectral optical coherence tomography in Vogt-KoyanagiHarada disease. Retina. 2011;31: 502–509. doi: 10.1097/ IAE.0b013e3182083beb

    63. Nakayama M, Keino H, Okada AA, Watanabe T, Taki W, Inoue M, et al. Enhanced depth optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease. Retina. 2012;32: 2061–2069. doi: 10.1097/IAE.0b013e318256205a

    64. Chi S, Luu KD, Cheng KL, Lim WK, Yap A. Visual function in VogtKoyanagi-Harada patients. Graefes Arch Clin Exp Ophthalmol. 2005;243: 785–790. doi: 10.1007/s00417-005-1156-3

    65. Yap A, Luu KD, Yeo Y, Chi S. Correlation between peripapillary atrophy and corticosteroid therapy in patients with VogtKoyanagi-Harada disease. Eye (Lond). 2008;22: 240–245. doi: 10.1038/sj.eye.6702591

    66. da Silva FT, Sakata VM, Nakashima A, Hirata AD, Olistors E, Takahashi VYa, et al. Improved depth optical coherence tomography in long-standing Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2012;97: 70–74. doi: 10.1136/ bjophthalmol-2012-302089

    67. Bushenaki N, Herbort K. Contribution of indocyanine green angiography to the evaluation and treatment of Vogt-KoyanagiHarada disease. Ophthalmology. 2001;108: 54–64. doi: 10.1016/ s0161-6420(00)00428-0

    68. Herbort K, Mantovani A, Bushenaki N. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic features and utility in patient monitoring. Int Ophthalmol. 2007;27: 173–182. doi: 10.1016/s0002-9394(14)71964-6

    69. Ho AS, Guyer DR, Fine SL. Macular hole. Surv Ophthalmol. 1998;42: 393–416. doi: 10.1016/s0039-6257(97)00132-x

    70. Reibaldi M, Bosha F, Avitabile T, Uva MG, Russo V, Zagari M, et al., Enhanced depth optical coherence tomography of the choroid for idiopathic macular hole: a cross-sectional prospective study. Am J Ophthalmol. 2011;151: 112–117. doi: 10.1016/j. ajo.2010.07.004

    71. Zeng J, Li J, Liu R, Chen H, Pan J, Tang S, et al. Choroidal thickness in both eyes of patients with unilateral idiopathic macular hole. Ophthalmology. 2012;119: 2328–2333. doi: 10.1016/j. ophtha.2012.06.008

    72. Ayton LN, Geimer RH, Luu KD. Choroidal thickness profiles in retinitis pigmentosa. Clinical experiment “Ophthalmol”. 2012; September 7. doi: 10.1111/j.1442-9071.2012.02867.x

    73. Dhoot DS, Ho S, Yuan A, Xu D, Shrivistava S, Ehlers J, et al. Assessment of choroidal thickness in retinitis pigmentosa using optical coherence tomography with enhanced depth imaging. Br J Ophthalmol. 2012;97: 66–69. doi: 10.3389/fmed.2021.783519

    74. 74. Schaal KB, Polliti S, Ditmar S. Is choroidal thickness important in idiopathic macular hole? Ophthalmology. 2012;109: 364–368. doi: 10.1007/s00347-012-2529-8

    75. Morgan KM, Schatz H. Involutional macular thinning. Condition of the premacular hole. Ophthalmology. 1986;93: 153–161. doi: 10.1016/s0161-6420(86)33767-9

    76. Falsini B, Anselmi GM, Marangoni D, D’Esposito F, Fadda A, Di Renzo A, et al. Subfoveal choroidal blood flow and central retinal function in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2011;52: 1064–1069. doi: 10.1167/iovs.10-5964

    77. Langham ME, Kramer T. Reduced choroidal blood flow associated with retinitis pigmentosa. Eye (Lond). 1990;4: 374–381. doi: 10.1038/eye.1990.50

    78. Shivdasani MN, Luu KD, Cicione R, Fallon JB, Allen J, Leuenberger J, et al. Evaluation of stimulus parameters and electrode geometry for an effective suprachoroidal retinal prosthesis. J Neural Eng. 2010;7: 036008. doi: 10.1088/1741-2560/7/3/036008

    79. Yeo J, Rahman W, Chen F, Hooper K, Tufail PA, et al. Choroidal imaging in inherited retinal disease using optical coherence tomography with advanced depth imaging. Graefes Arch Clin Exp Ophthalmol. 2010;248: 1719–1728. doi: 10.1007/s00417-010-1437-3

    80. Hidayat AA, Fine BS. Diabetic Choroidopathy. Light and electron microscopic observations of seven cases. Ophthalmology. 1985;92: 512–522. doi: 10.1016/S0161-6420(85)34013-7

    81. Fujiwara T, Imamura Y, Margolis R, Slakter JS, Spide RF. Enhanced optical coherence tomography of the uvea in high myopia patients. Am J Ophthalmol. 2009;148: 445–450. doi: 10.1016/j. ajo.2009.04.029

    82. Ozdemir H, Arf S, Karachorlu M. Maküla hastalıklarında optik koherens tomografi. Güneş Tıp Kitabevi. 2014. https:// flipflashpages.uniflip.com/3/34834/341527/pub/document.pdf